Evidence map›Paper›PMID 29410432›Full record

ArticleNature communications2018

Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space.

O Akinduro, T S Weber, H Ang, M L R Haltalli, N Ruivo, D Duarte, N M Rashidi, E D Hawkins, K R Duffy, C Lo Celso

Abstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. TCF1bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Differential Response and Recovery Dynamics of HSPC Populations FollowingInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

O AkinduroDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK.
T S WeberHamilton Institute, Maynooth University, Maynooth, Co Kildare, W23 WK26, Ireland.
H AngDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK.
M L R HaltalliDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK.
N RuivoDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK.
D DuarteDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK.
N M RashidiDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK.
E D HawkinsDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK.
K R DuffyHamilton Institute, Maynooth University, Maynooth, Co Kildare, W23 WK26, Ireland. ken.duffy@mu.ie.
C Lo CelsoDepartment of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ, UK. c.lo-celso@imperial.ac.uk.

Funding

Cancer Research UK 11831European Research Council 337066Wellcome Trust 105398
6 · The paper itself

Abstract

Leukaemia progressively invades bone marrow (BM), outcompeting healthy haematopoiesis by mechanisms that are not fully understood. Combining cell number measurements with a short-timescale dual pulse labelling method, we simultaneously determine the proliferation dynamics of primitive haematopoietic compartments and acute myeloid leukaemia (AML). We observe an unchanging proportion of AML cells entering S phase per hour throughout disease progression, with substantial BM egress at high levels of infiltration. For healthy haematopoiesis, we find haematopoietic stem cells (HSCs) make a significant contribution to cell production, but we phenotypically identify a quiescent subpopulation with enhanced engraftment ability. During AML progression, we observe that multipotent progenitors maintain a constant proportion entering S phase per hour, despite a dramatic decrease in the overall population size. Primitive populations are lost from BM with kinetics that are consistent with ousting irrespective of cell cycle state, with the exception of the quiescent HSC subpopulation, which is more resistant to elimination.

Indexed as

AnimalsBone MarrowCD48 AntigenCell CountCell ProliferationFemaleHematopoiesisHematopoietic Stem CellsHematopoietic Stem Cell TransplantationLeukemia, ExperimentalLeukemia, Myeloid, AcuteMice, Inbred C57BLMice, TransgenicS PhaseCD48 AntigenCd48 protein, mouse

Identifiers

PMID29410432
PMCPMC5802720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.